News in the Life Sciences Industry

MARTINSRIED, Germany and MUNICH, Nov. 21, 2019 /PRNewswire/ -- iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on novel immune checkpoint targets, announced today that its Vice President, Antibody Development, Stefanie Urlinger, PhD, delivered a podium... Read more ››

Copeptin mentioned as an important prognostic biomarker for risk stratification in patients with acute pulmonary embolism

BOSTON and BONN, Germany, Nov. 20, 2019 /PRNewswire/ -- IFM Therapeutics, LLC (IFM), a privately-held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system to treat inflammatory disorders and cancer, today announced the publication of... Read more ››

BRUSSELS, Nov. 20, 2019 /PRNewswire/ -- SEMI and 19 partners from 14 countries today launched an initiative to fill the skills gap and boost workforce diversity by tightening collaboration between the microelectronics industry and education providers. The project, dubbed METIS - Microelectronics... Read more ››

DUSSELDORF, Germany, Nov. 19, 2019 /PRNewswire/ -- Edan, a healthcare solutions provider, revealed their latest product series in its all five product lines, including Obstetrics and Gynecology, Patient Monitoring, In-Vitro Diagnostics, Diagnostic ECG, and Ultrasound, bringing a huge surprise... Read more ››

DÜSSELDORF, Germany, Nov. 18, 2019 /PRNewswire/ -- Nisonic AS, a startup co-founded by SINTEF and Cofounder in Norway, aims to make intracranial pressure (ICP) assessment as simple and easy as measuring body temperature. Nisonic is developing a novel method using properties of the optic nerve... Read more ››

- Data on 100 patients treated with Meril's Myval Transcatheter Heart Valve (THV) for severe symptomatic aortic valve stenosis demonstrated high safety and effectiveness at one-month in MyVal-1 clinical trial([1])

MONTREAL, Nov. 16, 2019 /PRNewswire/ - The Montreal Heart Institute (MHI) announced earlier today the results of its COLchicine Cardiovascular Outcomes Trial (COLCOT). This landmark study compared the effect of colchicine in the prevention of ischemic cardiovascular events in patients with a... Read more ››

ATHENS, Greece, Nov. 15, 2019 /PRNewswire/ -- A second baby has been born via the medical method of Maternal Spindle Transfer, in the context of clinical research being carried out by the scientific team of the 'Institute of Life' and 'Embryotools' in Greece. In the framework of this clinical... Read more ››

SUNDSVALL, Sweden, Nov. 15, 2019 /PRNewswire/ -- Permobil launches the most advanced wheelchair power assist system on the global market. A gesture-controlled smartwatch app enables users to simply tap the wheel to control the powerful SmartDrive MX2+ motor via Bluetooth. Steep slopes and uneven... Read more ››

BERLIN and BOSTON, Nov. 14, 2019 /PRNewswire/ -- Bayer and Dewpoint Therapeutics, a biotechnology company with sites in Boston and Dresden, Germany, today announced an option, research and license agreement worth up to USD 100 million. The partnership will leverage Dewpoint's proprietary platform... Read more ››